Expertise in
31
conditions

Dr. Jeremy M. Kilburn

Radiation Oncology
Medical Group Of The Carolinas-Radiation Oncology-Spartanburg
380 Serpentine Dr, 
Spartanburg, SC 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Expertise in
31
conditions
Medical Group Of The Carolinas-Radiation Oncology-Spartanburg
380 Serpentine Dr, 
Spartanburg, SC 

Overview

Jeremy Kilburn is a Radiation Oncologist practicing medicine in Spartanburg, South Carolina.

Dr. Kilburn is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Prostate Cancer.

He is actively involved in clinical research, co-authoring 7 peer reviewed articles and participating in 12 clinical trials. Dr. Kilburn is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in SC

Hospital Affiliations

Spartanburg Medical Center
Cherokee Medical Center
Pelham Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Medical Group Of The Carolinas-Radiation Oncology-Spartanburg
380 Serpentine Dr, Spartanburg, SC 29303
Other Locations
Medical Group Of The Carolinas-Radiation Oncology-Pelham
2759 S Highway 14, Greer, SC 29650

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Phase III Trial of Stereotactic Radiosurgery (SRS) Versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Brain Metastases From Small Cell Lung Cancer
Phase III Trial of Stereotactic Radiosurgery (SRS) Versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Brain Metastases From Small Cell Lung Cancer
Enrollment Status: Recruiting
Publish Date: August 17, 2026
Intervention Type: Procedure, Other, Radiation, Drug
Study Drug: Memantine Hydrochloride
Study Phase: Phase 3
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Enrollment Status: Active_not_recruiting
Publish Date: September 04, 2026
Intervention Type: Other
Study Phase: Early Phase 1
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
Enrollment Status: Completed
Publish Date: July 09, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Radiation, Other
Study Phase: Phase 3
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Completed
Publish Date: June 25, 2026
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: June 11, 2026
Intervention Type: Other, Drug, Procedure, Radiation
Study Drug: Atezolizumab
Study Phase: Phase 3
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer
Enrollment Status: Terminated
Publish Date: May 22, 2026
Intervention Type: Radiation
Study Phase: Phase 2
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 08, 2026
Intervention Type: Radiation, Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

7 Total Publications

Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)?
Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)?
Journal: Cureus
Published: March 02, 2016
Similar Doctors
Expertise in
51
conditions
Dr. Heather N. Allen
Radiation Oncology
Expertise in
51
conditions
Dr. Heather N. Allen
Radiation Oncology
Referral may be required

Medical Group Of The Carolinas-Radiation Oncology-Spartanburg

380 Serpentine Dr, 
Spartanburg, SC 
 (0.1 miles away)
864-560-6917
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Heather Allen is a Radiation Oncologist practicing medicine in Spartanburg, South Carolina. Dr. Allen is highly rated in 51 conditions, according to our data. Her clinical expertise encompasses Teratocarcinosarcoma, Olfactory Neuroblastoma, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Allen is currently accepting new patients.

Expertise in
23
conditions
Dr. Drew C. Monitto
Radiation Oncology
Expertise in
23
conditions
Dr. Drew C. Monitto
Radiation Oncology
Referral may be required

Medical Group Of The Carolinas-Radiation Oncology-Spartanburg

380 Serpentine Dr, 
Spartanburg, SC 
 (0.1 miles away)
864-560-6917
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Drew Monitto is a Radiation Oncologist practicing medicine in Spartanburg, South Carolina. Dr. Monitto is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Posterior Fossa Tumor, and Lung Cancer. Dr. Monitto is currently accepting new patients.

Expertise in
23
conditions
Dr. Daniel B. Fried
Radiation Oncology
Expertise in
23
conditions
Dr. Daniel B. Fried
Radiation Oncology
Referral may be required

Medical Group Of The Carolinas-Radiation Oncology-Spartanburg

380 Serpentine Dr, 
Spartanburg, SC 
 (0.1 miles away)
864-560-6917
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Fried is a Radiation Oncologist practicing medicine in Spartanburg, South Carolina. Dr. Fried is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Astrocytoma, and Lung Cancer. Dr. Fried is currently accepting new patients.

Frequently Asked Questions about Dr. Jeremy M. Kilburn

How do I make an appointment with Dr. Jeremy M. Kilburn?

You can book an appointment with Dr. Jeremy M. Kilburn by calling their office at 864-560-6917. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jeremy M. Kilburn a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeremy M. Kilburn is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jeremy M. Kilburn specialize in?

While Dr. Jeremy M. Kilburn is a Radiation Oncology, they have specific expertise in Lung Cancer, Familial Prostate Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Jeremy M. Kilburn participate in research or clinical trials?

Yes. Dr. Jeremy M. Kilburn has published 7 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Jeremy M. Kilburn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jeremy M. Kilburn accept my insurance?

Dr. Jeremy M. Kilburn accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 864-560-6917 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kilburn's expertise for a condition
ConditionClose
    View All 13 Distinguished Conditions
    View All 18 Advanced Conditions
    View All 74 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile